GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » LeMaitre Vascular Inc (NAS:LMAT) » Definitions » Cyclically Adjusted PS Ratio

LeMaitre Vascular (LeMaitre Vascular) Cyclically Adjusted PS Ratio : 9.49 (As of Apr. 30, 2024)


View and export this data going back to 2006. Start your Free Trial

What is LeMaitre Vascular Cyclically Adjusted PS Ratio?

As of today (2024-04-30), LeMaitre Vascular's current share price is $64.80. LeMaitre Vascular's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $6.83. LeMaitre Vascular's Cyclically Adjusted PS Ratio for today is 9.49.

The historical rank and industry rank for LeMaitre Vascular's Cyclically Adjusted PS Ratio or its related term are showing as below:

LMAT' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 1.73   Med: 6.86   Max: 12.25
Current: 9.69

During the past years, LeMaitre Vascular's highest Cyclically Adjusted PS Ratio was 12.25. The lowest was 1.73. And the median was 6.86.

LMAT's Cyclically Adjusted PS Ratio is ranked worse than
85.81% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 2.12 vs LMAT: 9.69

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

LeMaitre Vascular's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.177. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $6.83 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


LeMaitre Vascular Cyclically Adjusted PS Ratio Historical Data

The historical data trend for LeMaitre Vascular's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LeMaitre Vascular Cyclically Adjusted PS Ratio Chart

LeMaitre Vascular Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.59 8.07 8.87 7.31 8.31

LeMaitre Vascular Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.31 7.94 10.13 8.03 8.31

Competitive Comparison of LeMaitre Vascular's Cyclically Adjusted PS Ratio

For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LeMaitre Vascular's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where LeMaitre Vascular's Cyclically Adjusted PS Ratio falls into.



LeMaitre Vascular Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

LeMaitre Vascular's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=64.80/6.83
=9.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LeMaitre Vascular's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, LeMaitre Vascular's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.177/129.4194*129.4194
=2.177

Current CPI (Dec. 2023) = 129.4194.

LeMaitre Vascular Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 1.075 99.695 1.396
201406 1.098 100.560 1.413
201409 0.988 100.428 1.273
201412 1.054 99.070 1.377
201503 1.065 99.621 1.384
201506 1.101 100.684 1.415
201509 1.029 100.392 1.327
201512 1.086 99.792 1.408
201603 1.074 100.470 1.383
201606 1.180 101.688 1.502
201609 1.206 101.861 1.532
201612 1.185 101.863 1.506
201703 1.225 102.862 1.541
201706 1.289 103.349 1.614
201709 1.232 104.136 1.531
201712 1.293 104.011 1.609
201803 1.288 105.290 1.583
201806 1.334 106.317 1.624
201809 1.191 106.507 1.447
201812 1.406 105.998 1.717
201903 1.410 107.251 1.701
201906 1.456 108.070 1.744
201909 1.428 108.329 1.706
201912 1.474 108.420 1.759
202003 1.495 108.902 1.777
202006 1.218 108.767 1.449
202009 1.779 109.815 2.097
202012 1.821 109.897 2.144
202103 1.721 111.754 1.993
202106 1.940 114.631 2.190
202109 1.749 115.734 1.956
202112 1.784 117.630 1.963
202203 1.790 121.301 1.910
202206 1.903 125.017 1.970
202209 1.757 125.227 1.816
202212 1.842 125.222 1.904
202303 2.113 127.348 2.147
202306 2.232 128.729 2.244
202309 2.109 129.860 2.102
202312 2.177 129.419 2.177

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


LeMaitre Vascular  (NAS:LMAT) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


LeMaitre Vascular Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of LeMaitre Vascular's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


LeMaitre Vascular (LeMaitre Vascular) Business Description

Traded in Other Exchanges
Address
63 Second Avenue, Burlington, MA, USA, 01803
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are primarily used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes the largest proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Executives
George W Lemaitre director, 10 percent owner, officer: Chairman, President and CEO 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129
Bridget A Ross director C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747
John A Roush director C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409
Lawrence J Jasinski director SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760
David B Roberts director, officer: CFO and Director 55 BRADFORD STREET, NEEDHAM MA 02492
Trent G Kamke officer: Senior V. P., Operations 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132
Martha Shadan director 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445
Pellegrino Joseph P Jr officer: Executive V.P. Finance 68 BEACON STREET, BOSTON MA 02108
Michael H Thomas director P.O. BOX 2207, NOKOMIS FL 34274-2207
Peter R Gebauer officer: President, International OP AM WALDFELD 17, BAD SODEN 2M 65812
Michael T Wijas officer: VP of Sales, The Americas C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803
Lemaitre Cornelia W director, officer: V.P., Human Resources,Director 8 SUNSET ROCK ROAD, ANDOVER MA 01810
Russell D Hays director C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012
Robert V Linden officer: VP, North American Sales 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966
Thorndike William N Jr director HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199

LeMaitre Vascular (LeMaitre Vascular) Headlines